Shri Thanedar's Net Worth Reaches $41.5M: Inside a Congressman's Financial Portfolio

According to Quiver Quantitative’s financial tracking platform, Representative Shri Thanedar has accumulated an estimated net worth of $41.5M as of mid-2025, positioning him as one of the more financially substantial members of Congress. His investment portfolio generated approximately $271.7K in gains during a recent month, underscoring the significant role that equity markets play in his overall wealth composition.

Thanedar’s Congressional Wealth Ranking and Net Worth Composition

Shri Thanedar’s net worth places him at the 30th position among members of Congress, according to Quiver Quantitative’s live wealth estimates. Of his $41.5M total net worth, approximately $8.1M is held in publicly traded securities that the platform can monitor in real-time. This concentration in liquid equity assets provides insight into Thanedar’s investment strategy, which appears to favor easily tradable stocks over alternative wealth vehicles.

The congressman’s financial standing reflects significant accumulated wealth compared to the median congressional net worth, though he remains positioned below the wealthiest legislative members. His portfolio structure suggests an active approach to equity management rather than passive wealth retention.

Investment Strategy: Stock Trading and Market Performance

Quiver Quantitative has compiled data on $2.2M worth of trades by Representative Shri Thanedar drawn from STOCK Act filings—the congressional transparency mechanism that requires lawmakers to disclose securities transactions.

Several notable trades from Thanedar’s portfolio include:

• Apollo Global Management (APO): A transaction on January 23rd, 2023 involved the sale of up to $250K in shares. Since that divestment, APO has appreciated 113.8%, suggesting the congressman may have exited positions ahead of significant growth periods.

• American Express (AXP): The same date saw a $100K sale of American Express shares, which have subsequently risen 107.45%, indicating similar patterns in his trading execution.

• Tesla (TSLA): An August 1st, 2022 transaction involved liquidating up to $100K of Tesla stock. TSLA has gained 5.46% in the intervening period.

• Chromis Therapeutics (CHRS): Thanedar sold $50K of CHRS shares on January 23rd, 2023—this position has underperformed substantially, declining 90.41%.

• Apple (AAPL): An April 2nd, 2024 transaction resulted in a $50K reduction in Apple holdings. AAPL has since risen 25.07%.

These transactions provide a window into Thanedar’s portfolio management decisions and their timing relative to subsequent market movements.

Legislative Focus and Policy Agenda

Beyond his investment activities, Shri Thanedar has introduced several legislative proposals reflecting his policy priorities:

• H.R.4244: Aimed at amending Title XIX of the Social Security Act to prohibit Medicaid program payments for conversion therapy.

• H.R.2655: Targets modification of the Internal Revenue Code to phase out federal income taxation on unemployment compensation benefits.

• H.R.1893: Designated as the “LIONs Act of 2025,” representing another policy initiative on his legislative agenda.

Campaign Financing and Political Fund Management

Thanedar’s Q1 2025 FEC disclosure, filed on April 15th, 2025, revealed $45.8K in fundraising activities—ranking 556th among all Q1 reports filed that year. Individual donors accounted for 71.6% of this total, while the congressman reported $44.5K in corresponding expenditures (603rd highest among all reports).

Most significantly, Thanedar maintained $6.1M in cash reserves at the conclusion of the reporting period—positioning him 32nd nationally among House members in terms of available campaign resources.

Data Sources and Transparency Note

All financial data presented derives from Quiver Quantitative’s monitoring of official financial disclosures and STOCK Act filings. Net worth estimates should be understood as approximations potentially subject to methodological limitations or incomplete underlying data. For comprehensive details on data collection methodologies and disclaimers, Quiver Quantitative’s official documentation provides additional context.

This analysis draws from publicly available congressional financial records and represents Shri Thanedar’s disclosed financial positions as of the cited reporting dates.